|
protein complex biogenesis
|
GO:0070271 |
201 |
0.105
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
73 |
0.102
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.080
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.077
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.076
|
|
|
dendrite morphogenesis
|
GO:0048813 |
199 |
0.067
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
73 |
0.066
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.065
|
|
|
cell projection assembly
|
GO:0030031 |
94 |
0.063
|
|
|
mrna metabolic process
|
GO:0016071 |
124 |
0.055
|
|
|
nuclear migration
|
GO:0007097 |
20 |
0.055
|
|
|
sperm motility
|
GO:0030317 |
12 |
0.054
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.050
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.049
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.047
|
|
|
autophagy
|
GO:0006914 |
108 |
0.046
|
|
|
dendrite development
|
GO:0016358 |
204 |
0.043
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.042
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.041
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.041
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.041
|
|
|
cilium morphogenesis
|
GO:0060271 |
39 |
0.040
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.039
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.038
|
|
|
dna templated transcription elongation
|
GO:0006354 |
18 |
0.038
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.037
|
|
|
single organism behavior
|
GO:0044708 |
391 |
0.033
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.032
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.031
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.030
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.030
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.030
|
|
|
muscle structure development
|
GO:0061061 |
224 |
0.030
|
|
|
protein localization
|
GO:0008104 |
284 |
0.029
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.029
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.028
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.028
|
|
|
cellular protein complex assembly
|
GO:0043623 |
71 |
0.028
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.028
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
34 |
0.027
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.027
|
|
|
organic substance transport
|
GO:0071702 |
257 |
0.027
|
|
|
single organism membrane organization
|
GO:0044802 |
93 |
0.026
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.026
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
145 |
0.025
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.025
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
3 |
0.025
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.025
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.024
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.024
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.023
|
|
|
cytoplasmic transport
|
GO:0016482 |
130 |
0.023
|
|
|
eye development
|
GO:0001654 |
323 |
0.023
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
266 |
0.023
|
|
|
spermatogenesis
|
GO:0007283 |
200 |
0.022
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.022
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.022
|
|
|
positive regulation of cell motility
|
GO:2000147 |
3 |
0.022
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.022
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.021
|
|
|
response to organic substance
|
GO:0010033 |
284 |
0.021
|
|
|
oocyte axis specification
|
GO:0007309 |
108 |
0.021
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.021
|
|
|
nucleus localization
|
GO:0051647 |
34 |
0.020
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.020
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.020
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
73 |
0.020
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.020
|
|
|
chaperone mediated protein transport
|
GO:0072321 |
1 |
0.020
|
|
|
membrane organization
|
GO:0061024 |
112 |
0.020
|
|
|
regulation of cell projection organization
|
GO:0031344 |
92 |
0.020
|
|
|
growth
|
GO:0040007 |
359 |
0.020
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
17 |
0.019
|
|
|
axis specification
|
GO:0009798 |
167 |
0.019
|
|
|
establishment of protein localization
|
GO:0045184 |
163 |
0.019
|
|
|
intracellular protein transport
|
GO:0006886 |
104 |
0.019
|
|
|
cellular response to organic substance
|
GO:0071310 |
132 |
0.019
|
|
|
regionalization
|
GO:0003002 |
416 |
0.018
|
|
|
cell motility
|
GO:0048870 |
251 |
0.018
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.018
|
|
|
localization of cell
|
GO:0051674 |
257 |
0.018
|
|
|
centrosome organization
|
GO:0051297 |
163 |
0.018
|
|
|
regulation of cell development
|
GO:0060284 |
215 |
0.018
|
|
|
cilium organization
|
GO:0044782 |
41 |
0.018
|
|
|
pronuclear migration
|
GO:0035046 |
4 |
0.018
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.018
|
|
|
histolysis
|
GO:0007559 |
102 |
0.018
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.018
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
266 |
0.017
|
|
|
tissue death
|
GO:0016271 |
102 |
0.017
|
|
|
cell division
|
GO:0051301 |
248 |
0.017
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
145 |
0.017
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.017
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
136 |
0.017
|
|
|
central nervous system development
|
GO:0007417 |
201 |
0.017
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.016
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
128 |
0.016
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.016
|
|
|
regulation of multi organism process
|
GO:0043900 |
131 |
0.016
|
|
|
establishment of nucleus localization
|
GO:0040023 |
26 |
0.016
|
|
|
single organism cellular localization
|
GO:1902580 |
180 |
0.016
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.016
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.016
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
46 |
0.015
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.015
|
|
|
macroautophagy
|
GO:0016236 |
42 |
0.015
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.015
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
206 |
0.015
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.015
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.015
|
|
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.015
|
|
|
eye morphogenesis
|
GO:0048592 |
260 |
0.015
|
|
|
establishment of oocyte nucleus localization involved in oocyte dorsal ventral axis specification
|
GO:0030722 |
6 |
0.014
|
|
|
gene silencing by rna
|
GO:0031047 |
57 |
0.014
|
|
|
reproductive system development
|
GO:0061458 |
74 |
0.014
|
|
|
cell death
|
GO:0008219 |
279 |
0.014
|
|
|
segmentation
|
GO:0035282 |
207 |
0.014
|
|
|
salivary gland development
|
GO:0007431 |
162 |
0.014
|
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.014
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
167 |
0.014
|
|
|
transmembrane transport
|
GO:0055085 |
139 |
0.013
|
|
|
reproductive structure development
|
GO:0048608 |
74 |
0.013
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
271 |
0.013
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
85 |
0.013
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.013
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.013
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.013
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.013
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
145 |
0.013
|
|
|
actin filament organization
|
GO:0007015 |
126 |
0.013
|
|
|
embryonic development via the syncytial blastoderm
|
GO:0001700 |
148 |
0.012
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
276 |
0.012
|
|
|
embryonic axis specification
|
GO:0000578 |
107 |
0.012
|
|
|
negative regulation of signaling
|
GO:0023057 |
219 |
0.012
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.012
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.012
|
|
|
maintenance of cell polarity
|
GO:0030011 |
18 |
0.012
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.012
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.012
|
|
|
negative regulation of erbb signaling pathway
|
GO:1901185 |
29 |
0.012
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
45 |
0.012
|
|
|
post embryonic appendage morphogenesis
|
GO:0035120 |
385 |
0.012
|
|
|
synaptic transmission
|
GO:0007268 |
288 |
0.012
|
|
|
compound eye photoreceptor cell differentiation
|
GO:0001751 |
140 |
0.011
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.011
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
42 |
0.011
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
41 |
0.011
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
58 |
0.011
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.011
|
|
|
developmental maturation
|
GO:0021700 |
172 |
0.011
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.011
|
|
|
rna processing
|
GO:0006396 |
147 |
0.011
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.011
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.011
|
|
|
actin filament based process
|
GO:0030029 |
220 |
0.011
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.011
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.011
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.011
|
|
|
oocyte development
|
GO:0048599 |
124 |
0.011
|
|
|
positive regulation of cellular protein metabolic process
|
GO:0032270 |
118 |
0.011
|
|
|
neurological system process
|
GO:0050877 |
358 |
0.011
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.011
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.011
|
|
|
protein deubiquitination
|
GO:0016579 |
17 |
0.010
|
|
|
negative regulation of cell communication
|
GO:0010648 |
223 |
0.010
|
|
|
muscle organ development
|
GO:0007517 |
127 |
0.010
|
|
|
establishment or maintenance of polarity of follicular epithelium
|
GO:0016334 |
26 |
0.010
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.010
|
|
|
spinal cord development
|
GO:0021510 |
1 |
0.010
|
|
|
histone h4 acetylation
|
GO:0043967 |
13 |
0.010
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.010
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
4 |
0.010
|
|